Author

E. Dowling

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:clustering· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Research Focus:gene regulatory network inference· 1 Organism:human· 1 Approach:machine learning (classical)· 1 Assay:multiome· 1

Frequent Co-Authors

A. Korkut· 1 shared A. Luna· 1 shared B. Bozorgui· 1 shared C. Sander· 1 shared G. Yan· 1 shared J. H. Elnaggar· 1 shared P. Imanirad· 1 shared X. Li· 1 shared

Activity by Year

2020-2020 · peak 1/yr

Co-Author Collaboration Network

8 top collaborators · 28 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. Korkut

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Precision combination therapies based on recurrent oncogenic co-alterations

X. Li, E. Dowling, G. Yan, B. Bozorgui, P. Imanirad, J. H. Elnaggar, A. Luna, C. Sander, A. Korkut

The paper develops REFLECT, a method that maps recurrent co-alteration signatures to drug combinations using multi-omic data, validating its effectiveness across 201 cohorts and 10,392 patients.

bioRxiv · Jun 3, 2020Cancer Biology